everyledgerAn index of 587,017 U.S. nonprofits · computed from public IRS filings · current through 2024

The American Society Of Gene & Cell Therapy

Waukesha, WI / EIN 91-1766321 / Form 990 / latest filing 2023
Operating record · U.S. dollars
Fiscal yearRevenueExpensesNetReserve mo.Staff %
20101,642,8501,406,915235,9359.70%
20111,547,8281,593,491−45,6638.20%
20121,908,0511,503,644404,40711.90%
20131,672,8531,450,850222,00314.30%
20142,023,5081,675,652347,85614.90%
20152,219,3631,865,825353,53815.50%
20162,586,7211,929,028657,69319.60%
20173,515,1072,240,4341,274,67324.70%
20184,930,2683,397,5391,532,72921.20%
20196,509,2654,691,8421,817,42321.20%
20206,516,2104,511,4312,004,77927.418%
20218,934,6046,172,0372,762,56726.229%
202212,483,05210,958,6281,524,42415.626%
202316,370,70813,754,6272,616,08115.027%

In its most recent public year (2023), this organization brought in $2,616,081 more than it spent. Its reserves stood at about 15 months of spending, up from 9.7 in 2010. Staff pay was 27% of spending. $991,611 of its net assets are donor-restricted.

Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings

Follow this organization

A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works